GTB-6550

N/A

Report date: 2025/04/25 15:10:50

Base Information

Drug NameGTB-6550
Drug Alias NameGTB-6550
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionAnti-HER2
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsGastrointestinal NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGt Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesGt Biopharma Inc
Inactive CompaniesN/A
Active IndicationsGastrointestinal NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A